Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.
about
Keloids: pathogenesis, clinical features, and managementCurrent evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.Scar wars strategies. Target collagen.Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.Smooth muscle differentiation in scleroderma fibroblastic cells.Hereditary gingival fibromatosis: characteristics and novel putative pathogenic mechanisms.Clinical aspects of systemic sclerosis (scleroderma).Treatment of chronic hepatitis C in a patient affected by systemic sclerosis.Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases.Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma.Effect of lipopolysaccharide on the biological characteristics of human skin fibroblasts and hypertrophic scar tissue formation.The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
P2860
Q33910210-575FC55F-D11F-40FF-91FF-34ADB0D7D83CQ33973488-2EB00435-35B8-42AB-84F5-D19E1F0F2249Q34245307-6AE54867-A0F6-466F-A9A3-CC03706E6959Q34756317-24569314-F6D1-4572-B049-DD8E9AC24143Q35514544-D9662127-0430-4AF3-9E5D-8C401667F262Q35620268-D61D0E34-3161-438B-A553-6AADED4BAFD0Q35811553-C830F116-7728-42E3-9CE3-6F62361A2542Q36692626-258C4A56-373F-4448-A4AF-1405C2B1EF4FQ36824545-CD3EBDED-F49D-4BA2-92FC-3799B8751938Q37449686-3A1EC611-CC25-4ADC-9855-CAD01275B0C2Q38175063-8E0E6E9C-1B7B-4074-8DDB-7A2C36E868F1Q38296340-1F2E9F50-ED86-43B9-8FD7-31E1CD18AF3DQ40368781-8F2F10ED-7211-49EF-9EBC-F189D6043AC1Q44413643-56BE340E-9AF1-4856-94B5-724CCA5E3B83Q51011477-6025685D-1625-41F2-BA11-71684966AED1Q54241841-B7F53BB6-55D2-4C64-A03D-AD3F505BBBFE
P2860
Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Persistence of a reduced-colla ...... -term exposure to interferons.
@ast
Persistence of a reduced-colla ...... -term exposure to interferons.
@en
Persistence of a reduced-colla ...... -term exposure to interferons.
@nl
type
label
Persistence of a reduced-colla ...... -term exposure to interferons.
@ast
Persistence of a reduced-colla ...... -term exposure to interferons.
@en
Persistence of a reduced-colla ...... -term exposure to interferons.
@nl
prefLabel
Persistence of a reduced-colla ...... -term exposure to interferons.
@ast
Persistence of a reduced-colla ...... -term exposure to interferons.
@en
Persistence of a reduced-colla ...... -term exposure to interferons.
@nl
P2860
P356
P1476
Persistence of a reduced-colla ...... -term exposure to interferons.
@en
P2093
P2860
P304
P356
10.1172/JCI112956
P407
P577
1987-05-01T00:00:00Z